在儿童心脏移植后使用Everolimus和低剂量Tacrolimus:随机临床试验
Christopher S Almond1, Kevin P Daly2, Erin L Albers3
1Department of Pediatrics (Cardiology), Stanford University School of Medicine, Palo Alto, California.
JAMA
|September 17, 2025
概括
在儿童心脏移植患者中,Everolimus与低剂量Tacrolimus在预防主要移植不良事件方面与标准免疫抑制没有显著差异. 然而,这种疗法显示出潜在的安全益处,包括改善功能和减少细胞巨病毒感染.
科学领域:
- 移植免疫学
- 儿童心脏病学
- 药理学
背景情况:
- 在心脏移植后,Everolimus可能会减少排斥,心脏异位血管病 (CAV),慢性病 (CKD) 和细胞大脑病毒 (CMV) 的发生.
- 然而,人们担心新使用的Everolimus会增加与感染相关的死亡.
- 在移植后6个月开始使用的儿童的安全性和有效性尚不清楚.
研究的目的:
- 为了评估Everolimus与低剂量Tacrolimus的安全性和有效性.
- 预防心脏移植后儿童发生的重大不良事件.
主要方法:
- 一个多中心,随机,开放的试验招募了211名心脏移植后6个月的儿童.
- 参与者接受了Everolimus/低剂量Tacrolimus或标准剂量Tacrolimus/ mycophenolate mofetil,持续时间为30个月.
- 主要终点包括MATE-3 (疗效) 和MATE-6 (安全性) 评分.
主要成果:
- 在30个月的MATE-3分数 (疗效) 中没有显著差异.
- 在Everolimus组中,MATE-6评分 (安全性) 不高,符合非劣质性标准.
- 使用Everolimus与估计的球过率的改善和较低的CMV感染率有关.
结论:
- 在30个月的儿科心脏移植患者中,Everolimus与低剂量tacrolimus可与标准的免疫抑制药物进行比较,以预防关键不良事件.
- 这种疗法似乎是安全的,可能对功能和CMV预防有好处.
- 进一步的研究可能会支持在这个群体中使用它.
相关概念视频
01:28Kidney Transplant I: Introduction
297
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
297
01:26Kidney Transplant II: Surgical Procedure
270
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
01:16Kidney Transplant III: Nursing Management
286
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
286
01:24Tissue Transplantation
850
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
850